SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023676
Filing Date
2020-11-12
Accepted
2020-11-12 17:28:44
Documents
47
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20200930_10q.htm 10-Q 644485
2 EXHIBIT 31.1 ex_212224.htm EX-31.1 10642
3 EXHIBIT 31.2 ex_212225.htm EX-31.2 10655
4 EXHIBIT 32.1 ex_212226.htm EX-32.1 5454
5 EXHIBIT 32.2 ex_212227.htm EX-32.2 5452
12 logo.jpg GRAPHIC 5911
  Complete submission text file 0001437749-20-023676.txt   2873931

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dffn-20200930.xml EX-101.INS 462079
7 XBRL TAXONOMY EXTENSION SCHEMA dffn-20200930.xsd EX-101.SCH 35354
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20200930_cal.xml EX-101.CAL 24504
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20200930_def.xml EX-101.DEF 205567
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20200930_lab.xml EX-101.LAB 210267
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20200930_pre.xml EX-101.PRE 225057
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 201308153
SIC: 2834 Pharmaceutical Preparations